Viral screening before each cycle of assisted conception treatment is expensive and unnecessary: a survey of results from a UK inner city clinic

References

• Englert, Y., Lesage, B., Van Vooren, J. P., Liesnard, C., Place, I., Vannin, A. S., et al. (2004). Medically assisted reproduction in the presence of chronic viral diseases. Human reproduction update, 10, 149–162.
   PubMed Web of Science ®Google Scholar
• European Commission. (2004). Directive 2004/23/2004 of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Official Journal of the European Union. 7.4.2004 L 102/48-58.
   Google Scholar
• European Commission. (2006). Commission Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells. Official Journal of the European Union. 9.2.2006 L38/40, Annex III 4.2.
   Google Scholar
• Hart, R., Khalaf, Y., Lawson, R., Bickerstaff, H., Taylor, A., & Braude, P. (2001). Screening for HIV, hepatitis B and C infection in a population seeking assisted reproduction in an inner London hospital. BJOG: An international journal of obstetrics and gynaecology, 108, 654–656.
   PubMedGoogle Scholar
• Health Protection Agency. (2010). HIV in the United Kingdom: Report. 2010. Health Protection Report, 4(47). Accessed at http://www.hpa.org.uk/Publications/
   Google Scholar
• Hughes, C., Emerson, G., Grundy, K., Kelly, P., & Mocanu E. (2010). Is performing viral screening within 30 days of oocyte collection justified? Human Reproduction, 25, i239.
   Web of Science ®Google Scholar
• HMSO. (1990). Human Fertilisation and Embryology Act 1990. HMSO London 1990 c 37. Human Fertilisation and Embryology Act 1990: chapter 37. Publisher: London: H.M.S.O., 1990. ISBN: 0105437905. Accessed at http://www.legislation.gov.uk/ukpga/1990/37/pdfs/ukpga_19900037_en.pdf
   Google Scholar
• HMSO. (2008). Human Fertilisation and Embryology amended Act 2008. HMSO London 2008 c 22. Human Fertilisation and Embryology Act 2008: Chapter 22. (Public General Acts) HMSO (14 Nov 2008). ISBN-10: 0105422088. ISBN-13: 978-0105422082. Accessed at http://www.legislation.gov.uk/ukpga/2008/22/pdfs/ukpga_20080022_en.pdf
   Google Scholar
• Human Fertilisation and Embryology Authority. (2003). Code of Practice, 6th Edition. Accessed at http://www.hfea.gov.uk/docs/Code_of_Practice_Sixth_Edition.pdf
   Google Scholar
• Human Fertilisation and Embryology Authority. (2009). Code of Practice, 8th Edition. Accessed at http://www.hfea.gov.uk/code.html
   Google Scholar
• Lesourd, F., Izopet, J., Mervan, C., Payen, J. L., Sandres, K., Monrozies, X., et al. (2000). Transmissions of hepatitis C virus during the ancillary procedures for assisted conception. Human reproduction (Oxford, England), 15, 1083–1085.
   PubMed Web of Science ®Google Scholar
• Mocanu, E. (2010). O-244 EU tissues and cells directive–State of the art. Human Reproduction, 25, i96.
   Google Scholar
• National Institute for Health and Clinical Excellence (NICE). (2008). CG 62 Antenatal Care. Page 194. Accessed at http://www.nice.org.uk/nicemedia/live/11947/40145/40145.pdf
   Google Scholar
• Permalloo, N. & Chapple, J. (2010a). NHS antenatal and newborn screening programmes London region report 2009-10. London_Regional_Report_2009-10-1.pdf. Accessed at http://www.screening.nhs.uk/london.
   Google Scholar
• Permalloo, N. & Chapple, J. (2010b). NHS antenatal screening programmes London region Report 2008-09. London_Antenatal_Screening_Annual_Report_08-09_-_final-1.pdf. Accessed at http://www.screening.nhs.uk/london.
   Google Scholar
• Permalloo, N. & Chapple, J. (2010c). NHS antenatal and newborn screening programmes London region Report 2007-08. London_Antenatal_Screening_Annual_Report_07-08-final.pdf. Accessed at http://www.screening.nhs.uk/london.
   Google Scholar
• Pomeroy, K. O., Harris, S., Conaghan, J., Papadakis, M., Centola, G., Basuray, R., et al. (2010). Storage of cryopreserved reproductive tissues: Evidence that cross-contamination of infectious agents is a negligible risk. Fertility and sterility, 94, 1181–1188.
   PubMed Web of Science ®Google Scholar
• Semprini, A. E., Bujan, L., Englert, Y., Smith, C. G., Guibert, J., Hollander, L., et al. (2007). Establishing the safety profile of sperm washing followed by ART for the treatment of HIV discordant couples wishing to conceive. Human reproduction (Oxford, England), 22, 2793–4; author reply 2794.
   PubMed Web of Science ®Google Scholar
• Sharma, S., Gilling-Smith, C., Semprini, A. E., Barton, S. E., & Smith J. R. (2003). View 1: Assisted conception in couples with HIV infection. Sexually transmitted infections, 79, 185–188.
   PubMed Web of Science ®Google Scholar
• Tedder, R. S., Zuckerman, M. A., Goldstone, A. H., Hawkins, A. E., Fielding, A., Briggs, E. M., et al. (1995). Hepatitis B transmission from contaminated cryopreservation tank. Lancet, 346, 137–140.
   PubMed Web of Science ®Google Scholar
• van Os, H. C., Drogendijk, A. C., Fetter, W. P., Heijtink, R. A., & Zeilmaker G. H. (1991). The influence of contamination of culture medium with hepatitis B virus on the outcome of in vitro fertilization pregnancies. American journal of obstetrics and gynecology, 165, 152–159.
   PubMed Web of Science ®Google Scholar
• Wingfield, M., & Cottell E. (2010). Viral screening of couples undergoing partner donation in assisted reproduction with regard to EU Directives 2004/23/EC, 2006/17/EC and 2006/86/EC: What is the evidence for repeated screening? Human reproduction (Oxford, England), 25, 3058–3065.
   PubMed Web of Science ®Google Scholar
• Wortley, P. M., Hammett, T. A., & Fleming P. L. (1998). Donor insemination and human immunodeficiency virus transmission. Obstetrics and gynecology, 91, 515–518.
   PubMed Web of Science ®Google Scholar